Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques

Authors

Hannah A. D. King, Walter Reed Army Institute of Research
Rita E. Chen, Washington University School of Medicine in St. Louis
James B. Case, Washington University School of Medicine in St. Louis
Michael S. Diamond, Washington University School of Medicine in St. Louis
et al

Journal

Proceedings of the National Academy of Sciences of the United States of America

Publication Date

2021

Volume

118

Issue

38

First Page

e2106433118

Document Type

Open Access Publication

DOI

10.1073/pnas.2106433118

Rights and Permissions

King, H. A. D., Gordon Joyce, M., Lakhal-Naouar, I., Ahmed, A., Cincotta, C. M., Subra, C., . . . Bolton, D. L. (2021). Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences of the United States of America, 118(38) doi:10.1073/pnas.2106433118 This open access article is distributed under Creative Commons Attribution License 4.0 (CC BY)

Recommended Citation

King, Hannah A. D.; Chen, Rita E.; Case, James B.; Diamond, Michael S.; and al, et, "Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques." Proceedings of the National Academy of Sciences of the United States of America. 118, 38. e2106433118 (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10898